#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Dermatitis atopic Dementia Alzheimer's type Asthma Type 2 diabetes mellitus Breast cancer metastatic Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Cervix carcinoma Thalassaemia beta Nephropathy Hereditary angioedema with C1 esterase inhibitor deficiency Hereditary angioedema Growth hormone deficiency Propionic acidaemia Craniopharyngioma Familial dilated cardiomyopathy Spinal muscular atrophy Conjunctivitis allergic Systemic candida Cardiac sarcoidosis Malignant oligodendroglioma Neuropathic arthropathy More trials…

    Learn about Rare Diseases

    Wiskott-Aldrich syndrome – Life with Disease Friedreich’s ataxia – Diagnostics Hereditary ataxia – Trials in Disease Antisynthetase syndrome – Basic Information Pleomorphic leiomyosarcoma – Diagnostics Lymphangiosarcoma – Basic Information Mucopolysaccharidosis III – Treatment Mast cell activation syndrome – Trials in Disease Amyotrophic lateral sclerosis – Trials in Disease Mucous membrane pemphigoid – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Tipapkinogene Sovacivec Dexmedetomidine Hydrochloride IG-TREGS Ferrous Sulfate Salbutamol Levomepromazine Hydrochloride Ima203Cd8 Autologous Pancreatic Islets Pantothenate Sodium Abiraterone Acetate Vildagliptin Erythromycin ZINC GLUCONATE Nvl-655 Crovalimab Evx-01 HALOBETASOL PROPIONATE FOSMANOGEPIX Lacutamab Tasimelteon More therapies…

    Learn about Your Condition

    Lymphocytic leukaemia Monkeypox Metastatic gastric cancer Gallbladder cancer Labour pain Pancreatic failure Ischaemic skin ulcer Nodal osteoarthritis Juvenile idiopathic arthritis Cervix carcinoma Lennox-Gastaut syndrome Hepatobiliary cancer Bronchiectasis Hypoaesthesia Pulmonary hypertension More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Hopital Fernand Widal

Hopital Fernand Widal

200 Rue Du Faubourg Saint Denis, Paris, 75010, France

Want to learn more about this study or check if you can participate? Contact us.

  • A study testing xanomeline tartrate and trospium chloride for treating agitation in patients with Alzheimer’s disease

    Recruiting

    3 1
    Investigated Diseases:
    • Dementia Alzheimer’s type
    Investigated Drugs:
    • Trospium Chloride
    • Xanomeline Tartrate
    Czechia France Hungary Italy Poland

  • Effect of Hydroxocobalamin Acetate, Thiamine Hydrochloride, and Pyridoxine Hydrochloride Supplementation on Brain Injury in Outpatients with Alcohol Use Disorder

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Alcoholism
    Investigated Drugs:
    • Pyridoxine Hydrochloride
    • Thiamine Hydrochloride
    France

  • Comparing Abobotulinumtoxin A and Onabotulinumtoxin A for Adults with Upper Limb Spasticity

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Muscle spasticity
    Investigated Drugs:
    • Botulinum Toxin Type A
    • Botulinum Toxin Type A – Haemagglutinin Complex
    France

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!